Fig. 4From: Hydrophobic Drug-Loaded PEGylated Magnetic Liposomes for Drug-Controlled Release(a) Cell proliferation (%) of fibroblast (L-929) and human breast cancer (MCF-7) cell after incubation with various concentration of PEGylated liposomes and PEGylated magnetic liposomes for 48 h and (b) Cell viability (%) of MCF-7 cells treated with curcumin-loaded PEGylated liposomes and curcumin-loaded PEGylated magnetic liposomes with various concentrations for 48 hBack to article page